The Company is backed by its founders, business angels and venture capital and led by a management team with extensive experience in the development and commercialisation of novel diagnostic products. Momentum is headquartered near Cardiff and has a R&D facility near Oxford in the UK.
Momentum has created a new innovative technology for in-vitro diagnostic testing. ETGA® technology rapidly and universally detects viable micro-organisms using a unique combination of a phenotypic marker and ultra-sensitive molecular PCR measurement. Momentum is developing a number of products and applications for the use of its ETGA® technology.
The first of these products, Cognitor® Minus, targets the rapid universal exclusion of bacteria and fungi in blood in one day vs. five days in blood culture with an NPV of 99.5%. Cognitor® Minus is CE marked and was recently launched at ECCMID 2015.
19 Willowbrook Technology Park
Long Hanborough, St Mellons
Tel: +44 (0)29 2167 7910